Julie Dewey
Investor Relations Contact bij TREACE MEDICAL CONCEPTS, INC.
Profiel
Julie Dewey is currently the Chief Communications & Investor Relations Officer at Treace Medical Concepts, Inc. Prior to her current position, she held the same role at Nevro Corp.
from 2020 to 2023 and at Wright Medical Group NV from 2011 to 2020.
She also served as the Chief Communications Officer & Senior VP at Kyphon, Inc. from 2005 to 2007.
Ms. Dewey completed her undergraduate degree at the University of Southern California and holds an MBA from Pepperdine University.
Actieve functies van Julie Dewey
Bedrijven | Functie | Begin |
---|---|---|
TREACE MEDICAL CONCEPTS, INC. | Investor Relations Contact | 17-07-2023 |
Eerdere bekende functies van Julie Dewey
Bedrijven | Functie | Einde |
---|---|---|
NEVRO CORP. | Investor Relations Contact | 01-07-2023 |
WRIGHT MEDICAL GROUP N.V. | Public Communications Contact | 01-11-2020 |
Kyphon, Inc. | Public Communications Contact | 01-11-2007 |
Opleiding van Julie Dewey
University of Southern California | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
TREACE MEDICAL CONCEPTS, INC. | Health Technology |
NEVRO CORP. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Wright Medical Group NV
Wright Medical Group NV Medical SpecialtiesHealth Technology Wright Medical Group NV engages in the provision of medical device products. It operates through the following segments: U.S. Lower Extremities and Biologics; U.S. Upper Extremities; International Extremities and Biologics; and Corporate. The U.S. Lower Extremities and Biologics includes the sale of its lower extremities products, such as joint implants and bone fixation devices for the foot and ankle; and biologics products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth. The U.S. Upper Extremities segment focuses on joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; and products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries, and other ancillary products. The International Extremities and Biologics segment covers all lower and upper extremities products, as well as associated biologics products. The Corporate segment reflects general and administrative expenses not specifically associated with other segments. The company was founded by Frank O. Wright in 1950 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Kyphon, Inc. |